Laboratory investigations demonstrated clinically significant abnormalities: normocytic anemia (hemoglobin 91.0 g/L), pronounced hyperglobulinemia (globulin 76.18 g/L) with concomitant hypoalbuminemia (albumin 27.94 g/L), and elevated tumor markers (CA-125: 98.60 U/mL; CA 19–9: 38.87 U/mL). This evidence concerns the gene ALB and anemia.